Cat.#: ACPP-1287
| Despition | Dopamine Receptor D1 Blocking Peptide for Immunodepletion, Immunocompetition |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1413 | Human STX3 Protein (AC1413) | 5 µg | inquiry |
| ACPP-1131 | Recombinant Human/Murine/Rat BDNF Protein (AC1131) | 50 µg | inquiry |
| ACPP-1410 | Human MEOX2 Protein (AC1410) | 2 µg | inquiry |
| ACPP-1695 | Human LGALS9 Protein (AC1695) | 2 µg | inquiry |
| ACPP-1266 | ROR1 Blocking Peptide (AC1266) | 250 µg | inquiry |
| ACPP-1549 | Human VEGF C Protein (AC1549) | 2 µg | inquiry |
| ACPP-1312 | Human GDNF Protein (AC1312) | 2 µg | inquiry |
| ACPP-1120 | Human NRG1 Protein (AC1120) | 10 µg | inquiry |
| ACPP-1787 | Exenatide (AC1787) | 1 mg | inquiry |
| ACPP-1306 | FGFR2 Blocking Peptide (AC1306) | 250 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.